NASDAQ:PROF
Profound Medical Corp.
- Stock
Last Close
8.12
28/03 20:00
Market Cap
192.63M
Beta: 1.26
Volume Today
17.03K
Avg: 24.14K
PE Ratio
−6.25
PFCF: −8.27
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
cost and expenses | 4.34M - | 26.17M - | 37.16M 42.03% | 36.28M 2.37% | 36.47M 0.52% | ||||||
cost of revenue | 3.83M - | 3.92M 2.38% | 3.66M 6.66% | 2.87M 21.62% | |||||||
depreciation and amortization | 84.90K - | 2.23M - | 1.88M 15.74% | 4.13M 119.69% | 1.17M 71.73% | ||||||
ebitda | -6.18M - | -16.63M - | -28.41M 70.82% | -25.47M 10.34% | -27.97M 9.81% | ||||||
eps | -37.86 - | -4.98 86.85% | -2.93 41.16% | -2.44 16.72% | -1.52 37.70% | -1.39 8.55% | -1.25 10.07% | -1.50 20% | -1.40 6.67% | -1.37 2.14% | |
eps diluted | -37.86 - | -4.98 86.85% | -2.93 41.16% | -2.44 16.72% | -1.52 37.70% | -1.39 8.55% | -1.25 10.07% | -1.50 20% | -1.40 6.67% | -1.37 2.14% | |
general and administrative expenses | 1.95M - | 7.57M - | 10.31M 36.34% | 9.46M 8.23% | 9.17M 3.14% | ||||||
gross profit | 3.47M - | 2.95M 15.03% | 3.02M 2.34% | 4.46M 47.71% | |||||||
income before tax | -7.94M - | -21.58M - | -30.59M 41.79% | -28.38M 7.23% | -29.22M 2.96% | ||||||
income tax expense | 410.41K - | 45K - | 105K 133.33% | 287K 173.33% | -130.35K 145.42% | ||||||
interest expense | 143.01K - | 543K - | 303K 44.20% | 174K 42.57% | 932.80K 436.09% | ||||||
interest income | 8.53K - | 692K - | 205K 70.38% | 803K 291.71% | 1.67M 108.23% | ||||||
net income | -8.20M - | -11.80M 43.83% | -12.15M 2.93% | -14.97M 23.22% | -15.24M 1.84% | -15.46M 1.40% | -21.62M 39.88% | -30.70M 41.98% | -28.67M 6.61% | -29.09M 1.48% | |
operating expenses | 4.34M - | 8.09M 86.40% | 11.64M 43.90% | 15.51M 33.27% | 15.43M 0.50% | 17.56M 13.77% | 22.34M 27.23% | 33.24M 48.82% | 32.62M 1.87% | 33.60M 3.00% | |
operating income | -4.34M - | -11.22M 158.67% | -15.64M 39.36% | -17.63M 12.70% | -18.86M - | -30.29M 60.58% | -29.60M 2.27% | -29.14M 1.56% | |||
other expenses | 82.40K - | 0.00 100.00% | 1.57K 168,558,533,507,900% | 3.65K 132.26% | 3.76K 3.00% | ||||||
research and development expenses | 2.31M - | 9.91M - | 15.28M 54.13% | 14.69M 3.84% | 14.64M 0.34% | ||||||
revenue | 7.30M - | 6.87M 5.90% | 6.68M 2.79% | 7.33M 9.73% | |||||||
selling and marketing expenses | 4.86M - | 7.65M 57.45% | 8.47M 10.66% | 9.45M 11.63% | |||||||
selling general and administrative expenses | 1.95M - | 12.43M - | 17.97M 44.60% | 17.93M 0.18% | 18.96M 5.74% | ||||||
total other income expenses net | -1.53M - | -10.25K - | -2.71M - | -303K 88.84% | 1.22M 502.64% | -82.49K 106.76% | |||||
weighted average shs out | 216.68K - | 2.37M 993.05% | 4.15M 75.27% | 6.14M 47.93% | 10.04M 63.50% | 11.09M 10.51% | 17.29M 55.88% | 20.47M 18.34% | 20.47M 0% | 21.18M 3.50% | |
weighted average shs out dil | 216.68K - | 2.37M 993.05% | 4.15M 75.27% | 6.14M 47.93% | 10.04M 63.50% | 11.09M 10.51% | 17.29M 55.88% | 20.47M 18.34% | 20.47M 0% | 21.18M 3.50% |
All numbers in USD (except ratios and percentages)